NRXS Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 18.16%, SMA50 27.45%, SMA200 82.46%). The stock’s 14-day RSI is 65.34 (firm momentum), while the ATR of 0.42 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -8.23% below its high and over 327.82% above its low. Average 10-day trading volume of 154.27 thousand shares is below the 3-month average of 189.57 thousand, indicating normal recent market interest.

NeurAxis, Inc. generated EPS of -$1.02 over the past year. Five-year average earnings growth is -14.82%. Wall Street analysts project EPS growth of 51.14% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $13.00 to $7.00. The high target offers 79.31% upside. The low target suggests -3.45% downside. The mean target is $9.33. This offers 28.69% upside. NeurAxis, Inc. earnings surprise history is a mixed track record. The quarter that ended May 12, 2026, missed forecasts by 0.0%. The prior quarter beat by -20.93%. Over the last six quarters, Apple has recorded several small beats. These include 29.17% in May 12, 2025.

NeurAxis, Inc. has 9.86 million shares outstanding. The public float is 7.46 million shares, elevated short interest at 0.20% of float. This equals 14.72 thousand shares. The short ratio is 0.23 days. Institutional investors hold 10.75% of the float. Insiders own 20.39%. Carrico Brian Allen holds 348.18 thousand shares, Carrico Thomas Joeseph has 331.90 thousand shares and Aharon Gil has 286.14 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

The stock is currently mid-range between its 52-week high and low $2.20 and $9.33. With a market capitalization of about $89.79 million, NeurAxis, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.48). Key stats such as the average daily volume over the past year has been around 195.23 thousand shares, volume is running light vs its 52-week average. Headquartered in Carmel, IN, NeurAxis, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Brian Carrico, the company employs approximately 21 people and listed since August 09, 2023. NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States.

NeurAxis, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$4.71. This means the shares are trading below this model’s fair value.

NeurAxis, Inc. trades at a P/E ratio of -10.9, slightly below the S&P 500 average, with a price-to-sales ratio of 20.97 and a price-to-book ratio of 13.81 reflecting a rich premium to book value. The P/FCF stands at -14.79, also below market averages. Compared to sector medians, NeurAxis, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

NeurAxis, Inc. (AMEX:NRXS) shares are flat 2.42% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows NeurAxis, Inc. trading at a premium to the broader market with a P/E of -10.9. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $9.33, suggesting 28.69% upside. Our AI forecast model points to short-term strength (8.41% over two weeks), a medium-term rise (44.55% over three months), and a longer-term gain (304.83% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that NeurAxis, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 8.41%, with price expected at $7.86 by June 02, 2026, within a range of $7.45 to $8.28 3-Month Outlook: Projected rise of 44.55%, reaching $10.48 by August 17, 2026, with a range of $10.28 to $10.67. 1-Year Outlook: Projected gain of 304.83%, with price at $29.35 by May 19, 2027, within a range of $29.79 to $30.38.